Book release: March 6, 2026 on Amazon
Discovering Magic in Water that Makes Life Possible on Earth
Preventing and Treating: Alzheimer’s, Autism, Cardiovascular Disease and Childhood Epilepsy, and Male Infertility
Author: Dr. Dennis N. Crouse, BSc Biochemistry, – Harvard College, Ph.D. Chemistry – Harvard University – Chemistry Department, Post-graduate courses: Understanding Dementia – Wicking Faculty of Health, University of Tasmania, Fundamentals of Neuroscience – Harvard
Introduction
“If there is magic on this planet, it is contained in water.”
Loren Eiseley “The Immense Journey” 1946
I became interested in the “immense journey” of human evolution during my study of local artesian spring waters and the ability of some to magically support life while others were relatively sterile. Is there magic contained in water that makes life possible on earth and could this magic prevent and treat certain human diseases? This book focuses on answering this question by first discussing how humans evolved to protect themselves from an environmental toxin that is a causal (i.e. etiological) factor of the following diseases:
- Autism
- Childhood Epilepsy
- Alzheimer’s Disease
- Cardiovascular Disease
- Male Infertility
In 2013, I read a book that changed the way I viewed these diseases titled “The Story of The Human Body” 6 by Daniel E. Lieberman, an evolutionary biologist at Harvard. In his book Professor Lieberman points out that over thousands of years humans have evolved protection against toxins in our environment. This evolved protection has worked well until recently, when cultural practices counter to our evolution have exposed us to levels of some toxins that exceed our evolved protection mechanisms. For this reason, these cultural practices are called “dysevolutionary”. The mismatch between levels of toxins versus levels of evolved protection results in the above list of diseases being called “Mismatch Diseases”.
The rising prevalence during the last 100 years of these mismatch diseases with no evolutionary advantage cannot be explained by genetic mutations. Only genetic mutations with an evolutionary advantage can upset the evolutionary equilibrium. Therefore, mismatch diseases are caused by increasing human exposure to noninfectious environmental xenobiotic toxins.
My inquiry into mismatch diseases and dysevolutionary cultural practices began when my 85-year-old mother was diagnosed with two health conditions:
- Cardiovascular disease (CVD) that required several stents
- Amnestic mild cognitive impairment that was progressing to Alzheimer’s disease (AD)
As a son I wanted to help my mother to avoid end-stage AD and also prolong her life. I was successful in this regard as she lived to 97 without having end-stage AD. As a scientist I became interested in finding what caused these diseases in my mother. Without knowing the cause of a disease, it is almost impossible to prevent or cure the disease. My mother’s health conditions made me wonder if these two diseases had a common cause.
In 2022, I published a book titled “Finding a Cause and Potential Cures for Alzheimer’s Disease” in which aluminum is shown to be a causal factor of AD35. CVD that includes: arteriosclerosis (hardening of the arteries) and atherosclerosis (plaque on arterial inner walls) is associated with Alzheimer’s disease1-3. In fact, in autopsied brains of 84% of aged subjects, morphology is seen as a characteristic of both AD and CVD4. Deaths from CVD surged 60% globally over the last 30 years. In 2023, it was reported by the World Heart Association that deaths from CVD jumped globally from 12.1million in 1990 to 20.5million in 2021 making CVD the leading cause of death5. This rapid growth in CVD deaths points to an environmental factor, that is exponentially increasing with time, as being a causal factor of CVD. This book presents studies that support the contention: aluminum is a causal factor of CVD and AD.
CVD and AD are mismatch diseases. Mismatch diseases are diseases caused by increasing exposure to an environmental toxin that exceed the body’s evolved and carefully matched protection mechanisms6. Humans have slowly evolved over millions of years to protect themselves from aluminum, the third most abundant element in the earth’s crust. This evolution resulted in unique human evolutionary advantages that are described in this book. Dysevolutionary cultural practices are those practices that impair our ability to use our evolutionary advantages. The dysevolutionary cultural practices discussed in this book are:
- Accepting Worldwide Declining Male Fertility
- Adding Aluminum to Drinking Water
- Vaccinating Children with Aluminum-Containing Vaccines
- Drinking From an Aluminum Can, Cup, or Bottle
- Cooking in Aluminum Cookware
- Baking with an Aluminum-Containing Baking Powder
- Applying an Aluminum-Containing Lipstick or Lip Gloss
- Avoiding a Good Sweat
Treating CVD with Fiji Water is an example of a cultural evolution, fueled by social media, moving much quicker through a population than genetic mutations.
“We are winning too! My husband who is 75 had hypoxia issues, … out of control C-reactive protein, homocysteine, and blood pressure. My husband has the APOE4 gene and the MTHFR gene. He has never taken a statin. We decided never to take statins as the brain needs cholesterol.
We’ve been on this Journey 4 plus years. Prior to January of 2024 we used the Bredesen Protocol, along with Bredesen trained ND (Doctor of Naturopathic Medicine). We added drinking Fiji water almost a year ago in late January of 2024, because I trusted the science behind heavy metals and inflammation, and really there is no risk in trying this.
His August 2024 blood work and tests of his carotid artery showed a reduction to about 9-12 percent blockage from 78 percent blockage in 2021 and 2023. For the first time in 4 years his CRP and homocysteine levels were in the normal range. His blood pressure, previously considered uncontrollable, is now in the 117/80 range.
His tests were performed by Lifeline screening, who we have used since 2010, and Labcorp for blood work. These were done August 29th and 30th of 2024 and are the latest results. His carotid artery is now showing mild risk down from significant risk in 2021 to 2023.
His vascular surgeon, Dr. Hirschfeld in Las Vegas, had been monitoring him since late 2021 when his carotid artery was just under 80 percent occluded. Also, Labcorp results in August of 2024 for C-reactive protein were 1.05mg/L. That is down from the 3.5 to 3.9mg/L we were seeing up to and including 2023 testing. This was part of our NDs full range of tests begun in the fall of 2021 in response to my husband’s declining cognition. …. Drinking 1 liter of Fiji water a day was the only change we made from January of 2024 to December of 2024 and then 0.5 liter a day in 2025”.
Treating AD with Fiji Water is another example of how cultural evolution works. This anecdotal information was reported on October 10th 2025:
This may be too short a time period to attribute my husband’s improvements to the Fiji water. But here’s what happened: He is currently 89 and was diagnosed with Alzheimer’s almost two years ago. He has had numerous neurological evaluations plus an MRI and a Pet scan. In his last evaluation, he achieved a score of 19 on the MMSE.
In June of this year, he started drinking 32 ounces of Fiji water a day. Two months later, he had another neurological evaluation and his score was 25. His doctor said she had never seen this happen as he has almost tested out of Alzheimer’s. My husband and I were there to possibly start him on the infusions, but now we are taking a wait and see attitude.
His short-term memory is still not good, but it is a lot better than it was. I’m very hopeful!
These two anecdotal reports of treating CVD and AD with 1 liter or 32 ounces of Fiji Water a day are illustrative examples of how human mismatch diseases can be treated with waters rich in a form of silica that is the “magic” in water first suggested by Loren Eiseley in 1946. Anecdotal reports in this book are supportive and illustrative examples of the efficacy of using OSA rich water to treat human mismatch diseases caused by aluminum accumulation. They do not replace controlled clinical trials that should be funded and performed on large cohorts of different ethnicities. However, the anecdotal reports in this book do align with the known biochemical mechanisms described in this book.